Diarylquinolines

Definition

Diarylquinolines are a class of antibiotics that specifically target mycobacterial ATP synthase, an enzyme crucial for energy production in mycobacteria. They are most notably used to treat multi-drug resistant tuberculosis.

5 Must Know Facts For Your Next Test

1. Diarylquinolines inhibit the proton pump of mycobacterial ATP synthase.
2. Bedaquiline is the first diarylquinoline approved for the treatment of tuberculosis.
3. These drugs are particularly effective against multi-drug resistant strains of Mycobacterium tuberculosis.
4. Diarylquinolines have a unique mechanism compared to other anti-tuberculosis drugs, targeting bacterial energy metabolism.
5. Patients on diarylquinolines should be monitored for potential side effects such as hepatotoxicity and cardiac issues.

Related terms

ATP Synthase:

An enzyme involved in the synthesis of ATP, essential for cellular energy production.

Multi-Drug Resistant Tuberculosis (MDR-TB): A form of tuberculosis caused by bacteria that do not respond to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.

Hepatotoxicity: Chemical-driven liver damage often associated with drug therapy.